Keeley-Teton Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-55,434
Closed -$463K 370
2022
Q2
$463K Sell
55,434
-23,968
-30% -$335K 0.06% 296
2022
Q1
$1.81M Buy
79,402
+4,999
+7% +$122K 0.19% 173
2021
Q4
$2.05M Buy
74,403
+9,302
+14% +$249K 0.22% 165
2021
Q3
$1.81M Buy
65,101
+39,489
+154% +$1.12M 0.2% 169
2021
Q2
$751K Buy
+25,612
New +$776K 0.08% 235

Other funds holding BHC

Keeley-Teton Advisors's BHC Position: Q3 2022 in Review

Keeley-Teton Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 55,434 shares — an estimated $463K sold.

Keeley-Teton Advisors first reported a position in BHC in Q2 2021 and held it in 5 quarters. The position peaked at $2.05M in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Keeley-Teton Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Keeley-Teton Advisors sold 55,434 Bausch Health shares in Q3 2022, an estimated $463K.
  • Keeley-Teton Advisors first reported a position in Bausch Health in Q2 2021 and held it in 5 quarters.
  • Keeley-Teton Advisors's Bausch Health position peaked at $2.05M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Keeley-Teton Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.